Highlights

Including Capsule Summaries on-demand audio a comprehensive downloadable slideset and ClinicalThought commentaries this program provides expert insight on the hot topics from the HIV fall conferences.

Share

Program Content

Activities

  • Audio on Fall 2019 HIV Data
    Key Studies Influencing My Practice Following 2019 Fall HIV Conferences
    Audio
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 21, 2019

  • Slides on Fall 2019 HIV Data
    Clinical Impact of New HIV Data From Fall 2019 Conferences
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 02, 2019

  • PrEP at IDWeek 2019
    How New Data From IDWeek 2019 Estimate the Impact of PrEP Across Major US Cities
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

  • Data on Women at EACS 2019
    Implications of New Data From EACS 2019 for Women With HIV
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 29, 2020

Activities

PrEP in US Metropolitan Areas
Increased PrEP Uptake in US Metropolitan Statistical Areas During 2012-2017 Associated With Significant Reduction in New HIV Diagnoses Rate
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2019

DIAMOND
DIAMOND: High Virologic Suppression Rates Achieved Following Rapid Initiation of DRV/COBI/FTC/TAF Regardless of Baseline HIV-1 RNA Level or CD4+ Cell Count
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2019

GEMINI
GEMINI-1 and -2: Subgroup Analyses Consistent With Overall Safety and Efficacy Findings for DTG + 3TC in ART-Naive Adults at Wk 96
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 31, 2019

TANGO Subgroup Analysis
TANGO: Switch to DTG/3TC Maintains Virologic Suppression at Wk 48 Across Patient Demographics and Baseline Third Agent Classes
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2019

Weight Change With DOR
Low Weight Gain Over 96 Wks in Treatment-Naive Patients Initiating ART With Doravirine
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

RAL Safety in Pregnancy
No Increase in Adverse Birth Outcomes Following Exposure to Raltegravir in Pregnancy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

LATTE
LATTE: Durable Viral Suppression With Oral Cabotegravir + Rilpivirine Maintenance Therapy Through Wk 312
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

DISCOVER
DISCOVER: Renal Parameters and BMD Improved With FTC/TAF vs FTC/TDF for HIV PrEP at Wk 48
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2019

PrEP BMD Study
Longitudinal Cohort Study Demonstrates Notable Rate of > 3% BMD Loss Over 2 Yrs Among MSM Receiving TDF-Based PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2019

BIC/FTC/TAF in Women
BIC/FTC/TAF Safe and Efficacious in Women and Girls Across 5 Phase II/III Clinical Trials
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2019

Faculty

cover img faculity

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

cover img faculity

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

ProCE Banner

Supporters

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare